União Europeia - português - EMA (European Medicines Agency)

intervet international b.v. - ao vivo myxoma vetoriais rhd estirpe do vírus 009, ao vivo myxoma vetoriais rhd estirpe do vírus mk1899 - imunológicos para leporidae - coelhos - para a imunização ativa de coelhos a partir de 5 semanas de idade a partir de reduzir a mortalidade e sinais clínicos de doenças coelho hemorrágica da doença (rhd), causada pelo clássico rhd vírus (rhdv1) e rhd vírus de tipo 2 (rhdv2).

União Europeia - português - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - recombinante vírus da estomatite vesicular (strain indiana), com exclusão do envelope glicoprotéico, substituído com o zaire ebolavirus (strain kikwit 1995), a glicoproteína de superfície - febre hemorrágica Ébola - vacinas - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. o uso de ervebo deve estar em conformidade com as recomendações oficiais.

Portugal - português - DGAV (Direção Geral de Alimentação e Veterinária)

vírus da bursite infecciosa aviária atenuado vivo (ibdv), estirpe 1052 0.0 pu - galinhas , ovos embrionados de galinha

Portugal - português - DGAV (Direção Geral de Alimentação e Veterinária)

vírus vivo atenuado da dn, estirpe la sota 1000000.0 dio50 - galinhas

União Europeia - português - EMA (European Medicines Agency)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vacinas - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. o uso desta vacina deve ser de acordo com as recomendações oficiais.

União Europeia - português - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - porcos - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

União Europeia - português - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - frango - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

União Europeia - português - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imunologia para canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

União Europeia - português - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vacinas - active immunisation against h5 subtype of influenza a virus.

Portugal - português - DGAV (Direção Geral de Alimentação e Veterinária)

zoetis portugal, lda - vírus vivo atenuado da esgana, estirpe n-cdv 0.0 outra ; adenovírus canino tipo ii estirpe manhattan 0.0 outra ; vírus vivo da parainfluenza canina (cpi) estirpe cornell 0.0 outra ; vírus vivo atenuado de parvovírus canino, estirpe nl-35-d 0.0 outra ; leptospira canicola 0.0 outra ; leptospira icterohaemorrhagiae 0.0 outra - pó e solvente para suspensão injetável - vírus vivo da cinomose canina (esgana) + adenovírus vivo canino + vírus vivo parainfluenza canino + parvovírus vivo canino + leptospira inativada - cães (com mais de 5 semanas)